Less than a year after it was forced to withdraw GBT's sickle cell disease (SCD) therapy Oxbryta from all world markets after ...

In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

Noom claims its microdose approach allows users to lose up to 11 pounds (around 5kg) in one month and up to 17 pounds in two ...

At ASCO 2025 in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Dr Jason Williams, director of interventional ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

“Sexuality and intimacy are important aspects of quality of life and may also reduce some of the psychosocial distress ...

Confirmation of that has come in the form of an update (PDF) from the New Jersey Department of Labour and Workforce ...

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease ...